TY - JOUR
T1 - Reducing Substance Use-Related Harms
T2 - A Simulation-Optimization Framework for the Design and Evaluation of Harm Reduction Vending Machines
AU - Zafarnejad, Reyhaneh
AU - Griffin, Paul Marshal
AU - Zgierska, Aleksandra E.
AU - Zhang, Alice
N1 - Publisher Copyright:
© The Author(s) 2025
PY - 2025/11
Y1 - 2025/11
N2 - Introduction: This study introduces a simulation-optimization framework designed to optimize the services of opioid-focused harm reduction vending machines (HRVMs). Given the rising rates of overdose deaths and increased potential for infectious diseases among persons who inject drugs (PWID), HRVMs can become an important harm reduction (HR) strategy by providing essential supplies that mitigate health risks. Methods: We developed and validated an agent-based simulation–optimization framework to model the impact of HRVM-item allocation on the burden of opioid-related harms, accounting for demand dynamics, item restocking, and regional characteristics. The model evaluated health outcomes—cases of HIV, HCV, and fatal and nonfatal overdose—using disability-adjusted life-years (DALYs). Scenario-based analyses were conducted for different HRVM configurations, considering current legal limits on safer-injection supplies, fentanyl’s growing role as a drug of choice, and potential future policy changes. Results: The base scenario estimated optimal HRVM capacity allocation at approximately 48.5% fentanyl test strips (FTS), 26.2% naloxone, and 25.3% safer injection kits. However, sensitivity analyses showed significant variations based on fentanyl prevalence and willingness to use FTS. In scenarios of intentional fentanyl use with high FTS utilization, allocation favored FTS, while scenarios with low FTS utilization prioritized naloxone and injection kits. Adding addiction treatment referral services to HRVMs further reduced DALYs and societal costs, primarily by preventing fatal overdoses. Safer injection kits consistently reduced blood-borne infections compared with scenarios without these kits. Conclusions: The framework could aid in HRVMãrelated service planning and evaluation, highlighting the importance of strategic inventory management and linkages to addiction care for enhanced health outcomes. HRVMs show potential as scalable, cost-effective HR interventions, warranting further research on their impact on service accessibility and health outcomes. Highlights: A novel simulation-optimization framework for designing and evaluating harm reduction vending machines (HRVMs) is presented. Optimal baseline allocation for products in the HRVMs included fentanyl test strips (48.5%), naloxone (26.2%), and safer injection kits (25.3%). Sensitivity analysis indicated optimal allocations vary substantially by local fentanyl prevalence and by individual harm reduction behaviors surrounding the use of fentanyl test strips. HRVM implementation reduces societal costs and disability-adjusted life-years associated with substance use–related harms.
AB - Introduction: This study introduces a simulation-optimization framework designed to optimize the services of opioid-focused harm reduction vending machines (HRVMs). Given the rising rates of overdose deaths and increased potential for infectious diseases among persons who inject drugs (PWID), HRVMs can become an important harm reduction (HR) strategy by providing essential supplies that mitigate health risks. Methods: We developed and validated an agent-based simulation–optimization framework to model the impact of HRVM-item allocation on the burden of opioid-related harms, accounting for demand dynamics, item restocking, and regional characteristics. The model evaluated health outcomes—cases of HIV, HCV, and fatal and nonfatal overdose—using disability-adjusted life-years (DALYs). Scenario-based analyses were conducted for different HRVM configurations, considering current legal limits on safer-injection supplies, fentanyl’s growing role as a drug of choice, and potential future policy changes. Results: The base scenario estimated optimal HRVM capacity allocation at approximately 48.5% fentanyl test strips (FTS), 26.2% naloxone, and 25.3% safer injection kits. However, sensitivity analyses showed significant variations based on fentanyl prevalence and willingness to use FTS. In scenarios of intentional fentanyl use with high FTS utilization, allocation favored FTS, while scenarios with low FTS utilization prioritized naloxone and injection kits. Adding addiction treatment referral services to HRVMs further reduced DALYs and societal costs, primarily by preventing fatal overdoses. Safer injection kits consistently reduced blood-borne infections compared with scenarios without these kits. Conclusions: The framework could aid in HRVMãrelated service planning and evaluation, highlighting the importance of strategic inventory management and linkages to addiction care for enhanced health outcomes. HRVMs show potential as scalable, cost-effective HR interventions, warranting further research on their impact on service accessibility and health outcomes. Highlights: A novel simulation-optimization framework for designing and evaluating harm reduction vending machines (HRVMs) is presented. Optimal baseline allocation for products in the HRVMs included fentanyl test strips (48.5%), naloxone (26.2%), and safer injection kits (25.3%). Sensitivity analysis indicated optimal allocations vary substantially by local fentanyl prevalence and by individual harm reduction behaviors surrounding the use of fentanyl test strips. HRVM implementation reduces societal costs and disability-adjusted life-years associated with substance use–related harms.
UR - https://www.scopus.com/pages/publications/105018498045
UR - https://www.scopus.com/pages/publications/105018498045#tab=citedBy
U2 - 10.1177/0272989X251367719
DO - 10.1177/0272989X251367719
M3 - Article
C2 - 40990576
AN - SCOPUS:105018498045
SN - 0272-989X
VL - 45
SP - 1052
EP - 1069
JO - Medical Decision Making
JF - Medical Decision Making
IS - 8
ER -